EN
Home/United States/Blog/Where do GLP‑1 cash prices really come from? The makers’ own programs and the government price site
USUnited States Prices and costs

Where do GLP‑1 cash prices really come from? The makers’ own programs and the government price site

Who sets the price, what the government’s TrumpRx site does and doesn’t do, the fine print in the makers’ programs, and why we don’t quote discount-card prices.

Written for the United States, from US sources.

The short answer

The makers set them. Novo Nordisk and Eli Lilly publish self-pay prices and sell through their own programs, NovoCare and LillyDirect. TrumpRx.gov, a government site, lists those deals and links to them; it doesn’t sell anything itself. Payments made this way may not count toward an insurance deductible.

Key takeaways

  • GLP‑1 cash prices are set by the makers: Novo Nordisk publishes Wegovy at $149 to $399 a month by form and dose, and Eli Lilly publishes Zepbound at $299 to $449.1,2
  • TrumpRx.gov launched in February 2026 as a government-branded portal that links to makers’ discounts but does not sell or dispense medicines itself.3
  • TrumpRx shows starting-dose prices, such as $199 a month for the Wegovy pen and $299 for Zepbound, next to list prices of $1,349 and $1,087.4
  • Lilly’s $449 price for Zepbound’s higher doses applies only if each refill comes within 45 days; otherwise the price is $499 or $699.2
  • Cash payments through TrumpRx don’t count toward an insurance deductible, and once a deductible is met, insurance can cost less, experts told Managed Healthcare Executive.3
Before you go further
  • We quote only the makers’ published prices and TrumpRx’s listings. We don’t quote or link discount cards, pharmacies or telehealth services.
  • TrumpRx is an administration program. We describe what it does from its own site and a named news report, and take no side on the policy.
  • Every GLP‑1 needs a prescription, and the risks don’t change with the price: see our side effects guide.
On this page
  1. Who sets a GLP‑1 cash price?
  2. What is TrumpRx, and does it sell GLP‑1s?
  3. What is in the fine print?
  4. What about discount cards and store pharmacies?
  5. Should you pay cash or use insurance?
  6. Questions people ask
  7. How we researched this
  8. Sources

Who sets a GLP‑1 cash price?

The maker does: Novo Nordisk and Eli Lilly each publish a monthly self-pay price for every dose of their weight-loss medicines.1,2,5

A cash or self-pay price is what you pay with no insurance involved. The makers sell at these prices through their own programs: Novo Nordisk’s NovoCare and Eli Lilly’s LillyDirect.6,2 Lower cash prices followed a November 2025 agreement between both makers and the White House. Under it, starting doses of the GLP‑1 pills were to be $150 a month through TrumpRx.7

The makers’ own figures are in GLP‑1 costs without insurance. In short:

  • Wegovy: pens $349 ($199 for a new patient’s first 2 fills), HD $399, pills $149 to $299.1
  • Zepbound: $299 to $449 for vials and KwikPens.2
  • Foundayo: $149 to $299.5
  • Ozempic and Mounjaro (diabetes brands): Ozempic $199 to $499, Mounjaro $499.6,8

What is TrumpRx, and does it sell GLP‑1s?

No: TrumpRx.gov is a government website that lists makers’ cash deals and links to them; it doesn’t sell or dispense medicine.3

Managed Healthcare Executive describes it as “a government-branded, direct-to-consumer discount platform” that “functions as a coupon-driven portal requiring an active prescription”.3 It works only for cash-paying transactions.3

On October 12, 2026, its home page listed four GLP‑1 deals:4

ListingTrumpRx deal“Original Price”
Wegovy pill$149 a month$1,349
Wegovy pen$199 a month$1,349
Ozempic$199 a month$1,028
Zepbound$299 a month$1,087

As listed on TrumpRx.gov, checked Oct 12, 2026. In the order the site shows them; not ranked.4

These are the lowest, starting-dose prices. The makers’ pages show higher prices at higher doses: Wegovy pens are $349 after the first 2 fills, and Zepbound reaches $449.1,2

Free toolWork out a 6- or 12-month cost

Pick a medicine and a dose plan to see a year at makers’ self-pay prices. No sign-up.

Open the calculator

What is in the fine print?

Refill deadlines, offers that end, extra supplies and taxes: the makers’ terms change what you actually pay.2,5,1

  • Refill windows. Zepbound’s $449 price at 7.5 mg and up, and Foundayo’s $299 at 14.5 and 17.2 mg, need a refill within 45 days. Otherwise “regular prices will apply”: $499 or $699 for Zepbound.2,5
  • End dates. Wegovy’s $199 starter fills and Foundayo’s lower 2.5 and 5.5 mg prices run through December 31, 2026.1,5
  • Supplies. The Zepbound label says needles and syringes are not included with vials, and Lilly’s self-pay page says KwikPens need a separate pen-needle purchase.12,2
  • Taxes and fees. Lilly’s pages say “additional taxes and fees may apply”.5
  • A “month”. Novo Nordisk defines a month as 4 pens or 30 tablets.1 Four weekly pens last 28 days, so a year takes 13.

What about discount cards and store pharmacies?

We don’t quote them: their prices vary by pharmacy and day, and quoting one would point you to a seller.

Discount-card websites and some retail pharmacies also advertise GLP‑1 prices. We leave them out on purpose. We publish only prices a maker or the government has published, with a date.

Wherever you fill a prescription, the FDA says a safe pharmacy will always ask for a prescription and has a US address, a phone number and a licensed pharmacist.9 It warns against prices “that seem too good to be true”.9 Cheaper, unapproved copies are covered in compounded GLP‑1s in 2026.

Should you pay cash or use insurance?

Check both: cash payments through TrumpRx don’t count toward your deductible, and once it is met, insurance can cost much less.3

One expert told Managed Healthcare Executive that “once you’ve met your insurance deductible, you will end up paying much less through insurance”. A pharmacist added that listed costs “may not be their lowest cost option”.3

If your plan covers the medicine, the makers’ savings cards can bring a copay to $25. Medicare and Medicaid members are excluded from those cards.1,10 On Medicare, the GLP‑1 Bridge is $50 a month for people who qualify.11 Getting a plan to agree is covered in prior authorization, step by step.

Questions people ask

What is TrumpRx?

A government website, launched in February 2026, that lists makers’ cash prices and links to their discounts. It doesn’t sell or dispense medicine.3

Can I use insurance on TrumpRx?

No. TrumpRx deals are for cash-paying transactions, and payments don’t count toward your deductible.3

Is the TrumpRx price the same as LillyDirect or NovoCare?

TrumpRx shows the makers’ starting-dose deals, such as $299 for Zepbound. The makers’ own pages list every dose, including higher prices at higher doses.4,2,1

Do I need a prescription for a cash price?

Yes. TrumpRx needs an active prescription, and Lilly’s self-pay offers say “Prescription required”.3,5

Why don’t you list discount-card prices?

They vary by pharmacy and change often, and quoting one points readers to a seller. We use only maker and government prices, with a date.

How we researched this

We read the makers’ price pages and TrumpRx.gov on October 12, 2026, and used a named, dated news report for how TrumpRx works. The November 2025 agreement comes from a White House fact sheet.1,2,4,3,7

We link to the makers’ information pages but not to pages where you can buy medicine; those are cited as plain text.

Before you move on

  • Price the dose you’ll be on, not the starting dose.
  • Note refill deadlines and offer end dates.
  • Add needles, syringes, taxes and fees.
  • Ask your plan whether cash payments count toward your deductible.
  • Check the pharmacy is state-licensed.

More from the US blog

About GLP Guidebook

The monthly US update

An independent guide to GLP‑1 medicines. We don’t sell medicines, take drug-company money, earn commissions or link to any provider. Once a month: FDA approvals and warnings, Medicare and Medicaid changes, and makers’ price changes. How we write

Was this post easy to understand?

Sources

  1. Novo Nordisk. Price your Wegovy (NovoCare): self-pay prices by dose, new-patient offer and savings-card terms. Checked Oct 12, 2026. Link
  2. Eli Lilly. LillyDirect Zepbound self-pay page (vial and KwikPen prices; regular prices if not refilled within 45 days), lilly.com/lillydirect. Checked Oct 12, 2026. Not linked because the page sells medicine.
  3. Managed Healthcare Executive. TrumpRx launches; some experts question its long-term value. February 6, 2026. Link
  4. TrumpRx.gov. Home page GLP-1 listings (“Lowest Presidential Deal” and “Original Price”). Checked Oct 12, 2026. Link
  5. Eli Lilly. LillyDirect Foundayo self-pay page (prices by dose; 2.5 mg and 5.5 mg prices temporarily reduced through Dec 31, 2026), lilly.com/lillydirect. Checked Oct 12, 2026. Not linked because the page sells medicine.
  6. Novo Nordisk. NovoCare Pharmacy, information for health care providers: self-pay prices and footnotes for Wegovy and Ozempic. Checked Oct 12, 2026. Link
  7. The White House. Fact sheet: major developments in bringing Most-Favored-Nation pricing to American patients. November 6, 2025. Link
  8. Eli Lilly. LillyDirect Mounjaro self-pay page (all doses), lilly.com/lillydirect. Checked Oct 12, 2026. Not linked because the page sells medicine.
  9. FDA. How to buy medicines safely from an online pharmacy. Consumer update, January 2, 2025. Link
  10. Eli Lilly. Zepbound coverage and savings, for health care providers. Checked Oct 12, 2026. Link
  11. Medicare.gov. Medicare GLP-1 Bridge: GLP-1 drugs for $50 a month (fact sheet). CMS Product No. 12234, June 2026. Link
  12. Eli Lilly. Zepbound (tirzepatide): US prescribing information and Instructions for Use (vial: “The needle and syringe are not included”). Revised 8/2026. Link

Last checked Oct 12, 2026 · Next review due Apr 12, 2027 · Report an error

How this post was made. Written by the GLP Guidebook team from the sources above. It’s general information, not medical advice. Talk to your doctor, pharmacist or prescriber before starting, stopping or changing any medicine. We don’t sell, prescribe or recommend any brand or provider. How we write